Sleiman, Joseph, Aline Charabaty, and Asad ur Rahman. 2021. “Do Pharmacokinetics Justify Dose-Optimization for Loss of Response to Vedolizumab in IBD?”. @Gijournal 1 (1). https://doi.org/10.52697/gijournal.v1i1.23.